CoreMedic Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 3

CoreMedic General Information

Description

Developer of a transcatheter device designed to improve the treatment for patients with mitral heart valve regurgitation. The company's device is used to replace the ruptured or elongated chordae of the valve and re-establishes the connection of the leaflet of the valve with the papillary muscle to restore the proper function, enabling patients with a minimally invasive alternative to traditional open-heart surgery.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Fritz-Reichle-Ring 2
  • 78315 Radolfzell
  • Germany
+49 07732
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Vertical(s)
Corporate Office
  • Fritz-Reichle-Ring 2
  • 78315 Radolfzell
  • Germany
+49 07732

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CoreMedic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 11-Feb-2025 Completed Product Development
1. Later Stage VC 01-Aug-2017 Completed Product Development
To view CoreMedic’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CoreMedic Patents

CoreMedic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2022526046-A A device for repairing the atrioventricular heart valve Active 19-Mar-2019
JP-7550212-B2 Devices for repairing atrioventricular heart valves Active 19-Mar-2019
EP-3941397-A1 Instrument for repairing an atrioventricular heart valve Active 19-Mar-2019
EP-3941397-B1 Instrument for repairing an atrioventricular heart valve Active 19-Mar-2019
EP-3941397-C0 Instrument for repairing an atrioventricular heart valve Active 19-Mar-2019 A61B17/06
To view CoreMedic’s complete patent history, request access »

CoreMedic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CoreMedic Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
MIG AG Venture Capital Minority
Prettybrook Partners PE/Buyout Minority
SHS Capital PE/Buyout Minority
To view CoreMedic’s complete investors history, request access »

CoreMedic FAQs

  • When was CoreMedic founded?

    CoreMedic was founded in 2012.

  • Where is CoreMedic headquartered?

    CoreMedic is headquartered in Radolfzell, Germany.

  • What is the size of CoreMedic?

    CoreMedic has 8 total employees.

  • What industry is CoreMedic in?

    CoreMedic’s primary industry is Therapeutic Devices.

  • Is CoreMedic a private or public company?

    CoreMedic is a Private company.

  • What is CoreMedic’s current revenue?

    The current revenue for CoreMedic is .

  • Who are CoreMedic’s investors?

    MIG AG, Prettybrook Partners, and SHS Capital have invested in CoreMedic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process